The COVID-19 pandemic has fundamentally transformed global healthcare systems and vaccine technologies. The accelerated approval and rapid distribution of mRNA vaccines introduced a new paradigm in ...

A study indicates that longer Paxlovid treatments could improve long COVID symptoms in some patients, highlighting the need for tailored antiviral strategies.

VYD-2311 is under clinical development by Invivyd and currently in Phase I for Coronavirus Disease 2019 (COVID-19).

A leading health expert from the World Health Organisation has shared vital information about the human metapneumovirus (HMPV ...

Simaravibart is under clinical development by Contraria Biotech and currently in Phase III for Coronavirus Disease 2019 (COVID-19).

Beijing has reported a surge in cases of the flu-like human metapneumovirus (HMPV) - but how does it compare to the deadly ...

It's hard to believe it's been five years since the start of COVID-19. This timeline serves as a reminder of those early days ...

A viral outbreak in China sounds alarmingly familiar to 2019, back in the days before most of us had ever heard of the ...

Merck & Co.’s Covid-19 antivirals are getting a new lease of life in post-pandemic China, as cat owners seize on them as ...

Wen: The majority of people with diarrhea, vomiting and stomach cramps have viral gastroenteritis caused by the very ...

Bali monitors flights from China as Beijing urged to be transparent over cases - Authorities in Bali have asked nationals ...

An Infectious Disease Specialist recalls what we have learned after Covid was first identified five years ago.